Trademark: 98196287
Word
ALENTIS
Status Date
Tuesday, September 10, 2024
Registration Number
7500787
Registration Date
Tuesday, September 10, 2024
Filing Date
Monday, September 25, 2023
Published for Opposition
Tuesday, June 25, 2024
5 Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment; pharmaceutical preparations and substances for cancer treatment; pharmaceutical preparations and substances for cancer prevention
The mark consists of the literal element "Alentis" where the "A" is in uppercase and in the shape of a stylized triangle and is followed by "lentis" in all lowercase letters.
Color is not claimed as a feature of the mark.
Sep 28, 2023
New Application Entered
Oct 10, 2023
New Application Office Supplied Data Entered
Oct 1, 2023
Teas Voluntary Amendment Received
Oct 11, 2023
Notice Of Design Search Code E-Mailed
Feb 22, 2024
Assigned To Lie
Feb 22, 2024
Preliminary/Voluntary Amendment - Entered
May 16, 2024
Assigned To Examiner
May 17, 2024
Approved For Pub - Principal Register
Jun 5, 2024
Notification Of Notice Of Publication E-Mailed
Jun 25, 2024
Published For Opposition
Jun 25, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2024
Registered-Principal Register
Sep 10, 2024
Notice Of Registration Confirmation Emailed
Trademark Alertz updated from USPTO on 2030-01-24
